Unilever Goes To Multi-Omics Data With Goal Of Personalizing Acne Intervention

Unilever aims to use Onegevity’s AI and multi-omics database as a platform to develop “new diagnostic models that offer bespoke acne management regiments,” according to the New York-based health intelligence company’s announcement.

Unilever will leverage multi-omics data on acne and skin physiology provided by Onegevity in its exploration of personalized acne solutions, according to a 16 March announcement.

“Using Onegevity's artificial intelligence (AI) and machine learning capabilities to assess the billions of biological features that influence the state...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Strategy

More from Business